| Malani K, Loscalzo K, Elfanagely Y, Promrat K. "Exploring Colorectal Cancer Screening Reach Among United States Veterans: Analyzing Clinical, Sociodemographic, and Social Determinants of Health-Based Patient Factors Across Screening Methods: Analyzing Clinical, Sociodemographic, and Social Determinants of Health-based Patient Factors Across Screening Methods." Journal of clinical gastroenterology, 2024. |
| Lyu X, Liu B, Li Y, Wang Y, Miskovsky J, Gaitanis M, Promrat K, Wu WC. "Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000-2019)." Journal of Clinical Medicine, vol. 13, no. 19, 2024. |
| Malani K, Elfanagely Y, Promrat K. "Lack of Adherence to Guidelines on Follow-Up Colonoscopy after an Abnormal Stool Occult Blood Test." Journal of gastrointestinal cancer, vol. 55, no. 3, 2024, pp. 1456-1459. |
| Vassilopoulos A, Kalligeros M, Vassilopoulos S, Shehadeh F, Benitez G, Kaczynski M, Lazaridou I, Promrat K, Wands JR, Mylonakis E. "Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis." Digestive Diseases and Sciences, vol. 69, no. 3, 2024, pp. 989-1003. |
| Malani K, Sunkara N, Selig T, Tanzer JR, Elfanagely Y, Min M, Promrat K. "Sociodemographic Factors Associated with Mailed Fecal Immunochemical Testing Uptake During the COVID-19 Pandemic: Substance Use Linked to Reduced Screening Completion in Younger Adults." Journal of gastrointestinal cancer, vol. 55, no. 3, 2024, pp. 1453-1455. |
| Malani K, Elfanagely Y, Promrat K. "Understanding Patient Perspectives to Improve Colorectal Cancer Screening Following the COVID-19 Pandemic: Assessment of a Mailed Fecal Immunochemical Testing Program." Journal of gastrointestinal cancer, vol. 55, no. 3, 2024, pp. 1460-1462. |
| Robertson DJ, Dominitz JA, Beed A, Boardman KD, Del Curto BJ, Guarino PD, Imperiale TF, LaCasse A, Larson MF, Gupta S, Lieberman D, Planeta B, Shaukat A, Sultan S, Menees SB, Saini SD, Schoenfeld P, Goebel S, von Rosenvinge EC, Baffy G, Halasz I, Pedrosa MC, Kahng LS, Cassim R, Greer KB, Kinnard MF, Bhatt DB, Dunbar KB, Harford WV Jr, Mengshol JA, Olson JE, Patel SG, Antaki F, Fisher DA, Sullivan BA, Lenza C, Prajapati DN, Wong H, Beyth R, Lieb JG 2nd, Manlolo J, Ona FV, Cole RA, Khalaf N, Kahi CJ, Kohli DR, Rai T, Sharma P, Anastasiou J, Hagedorn C, Fernando RS, Jackson CS, Jamal MM, Lee RH, Merchant F, May FP, Pisegna JR, Omer E, Parajuli D, Said A, Nguyen TD, Tombazzi CR, Feldman PA, Jacob L, Koppelman RN, Lehenbauer KP, Desai DS, Madhoun MF, Tierney WM, Ho MQ, Hockman HJ, Lopez C, Carter Paulson E, Tobi M, Pinillos HL, Young M, Ho NC, Mascarenhas R, Promrat K, Mutha PR, Pandak WM Jr, Shah T, Schubert M, Pancotto FS, Gawron AJ, Underwood AE, Ho SB, Magno-Pagatzaurtundua P, Toro DH, Beymer CH, Kaz AM, Elwing J, Gill JA, Goldsmith SF, Yao MD, Protiva P, Pohl H, Kyriakides T, CONFIRM Study Group. "Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial." JAMA Network Open, vol. 6, no. 7, 2023, pp. e2321730. |
| Mohamed MF, Wadhavkar N, Elfanagely Y, Marino D, Beran A, Abdallah M, Promrat K. "Etiologies and Outcomes of Transaminase Elevation > 1000 IU/L: A Systematic Review and Meta-Analysis." Digestive Diseases and Sciences, vol. 68, no. 7, 2023, pp. 2843-2852. |
| Vassilopoulos S, Kalligeros M, Vassilopoulos A, Shehadeh F, Benitez G, Kaczynski M, Lazaridou I, Promrat K, Wands JR, Mylonakis E. "Impact of prior HBV, HAV, and HEV infection on non-alcoholic fatty liver disease." Journal of viral hepatitis, vol. 30, no. 8, 2023, pp. 685-693. |
| Kalligeros, Markos, Vassilopoulos, Athanasios, Shehadeh, Fadi, Vassilopoulos, Stephanos, Lazaridou, Ingrid, Mylonakis, Eleftherios, Promrat, Kittichai, Wands, Jack R. "Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis." Clinical Gastroenterology and Hepatology, 2023. |
| Kalligeros M, Vassilopoulos S, Vassilopoulos A, Shehadeh F, Lazaridou I, Mylonakis E, Promrat K, Wands JR. "Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020." Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, vol. 36, no. 6, 2023, pp. 670-677. |
| Atsawarungruangkit A, Laoveeravat P, Promrat K. "Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database." World Journal of Hepatology, vol. 13, no. 10, 2021, pp. 1417-1427. |
| Atsawarungruangkit A, Elfanagely Y, Pan J, Anderson K, Scharfen J, Promrat K. "Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States' adolescent population." World Journal of Hepatology, vol. 13, no. 7, 2021, pp. 790-803. |
| Imperiale TF, Daggy JK, Imler TD, Sherer EA, Kahi CJ, Larson J, Cardwell J, Johnson CS, Ahnen DJ, Antaki F, Ashley C, Baffy G, Dominitz JA, Hou J, Korsten MA, Nagar A, Promrat K, Robertson DJ, Saini S, Shergill A, Smalley WE. "Prevalence of Advanced Colorectal Neoplasia in Veterans: Effects of Age, Sex, and Race/Ethnicity." Journal of clinical gastroenterology, vol. 55, no. 10, 2021, pp. 876-883. |
| Chung, Waihong, Promrat, Kittichai, Wands, Jack. "Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases." World Journal of Hepatology, vol. 12, no. 9, 2020, pp. 533-557. |
| Pan, Jason Jeng, Promrat, Kittichai. "Doxycycline-Induced Autoimmune Hepatitis." ACG Case Reports Journal, vol. 7, no. 8, 2020, pp. e00440. |
| Mogul A, Teixeira E, McAuliffe L, Promrat K, Zullo AR. "Effectiveness of crushed sofosbuvir-velpatasvir in a patient with dysphagia." American Journal of Health-system Pharmacy, vol. 77, no. 6, 2020, pp. 417-418. |
| Siddique O, Siddique AS, Machan JT, Promrat K. "Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants." Clinical and Experimental Hepatology, vol. 4, no. 1, 2018, pp. 28-34. |
| Fast, Loren D., Mishra, Sasmita, Promrat, Kittichai, Losikoff, Phyllis T., Gregory, Stephen H. "Viral epitope-specific T cell responses induced in chronic, hepatitis C virus-infected patients." Digestive and Liver Disease, vol. 49, no. 6, 2017, pp. 709-713. |
| Olefson, Sidney, Jackson, Melissa, Grand, David J., Charpentier, Kevin P., Makwana, Nirav. "Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique." Journal of Clinical and Translational Hepatology, vol. 3, no. 4, 2015, pp. 246-53. |
| Olefson, Sidney, Jackson, Melissa, Grand, David J., Charpentier, Kevin P., Makwana, Nirav. "Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique." Journal of Clinical and Translational Hepatology, vol. 3, no. 4, 2015, pp. 246-253. |
| Imler TD, Morea J, Kahi C, Sherer EA, Cardwell J, Johnson CS, Xu H, Ahnen D, Antaki F, Ashley C, Baffy G, Cho I, Dominitz J, Hou J, Korsten M, Nagar A, Promrat K, Robertson D, Saini S, Shergill A, Smalley W, Imperiale TF. "Multi-center colonoscopy quality measurement utilizing natural language processing." American Journal of Gastroenterology, vol. 110, no. 4, 2015, pp. 543-52. |
| Beland MD, Brown SF, Machan JT, Taliano RJ, Promrat K, Cronan JJ. "A Pilot Study Estimating Liver Fibrosis With Ultrasound Shear-Wave Elastography: Does the Cause of Liver Disease or Location of Measurement Affect Performance?." American Journal of Roentgenology, vol. 203, no. 3, 2014, pp. W267-73. |
| Sanyal AJ, Abdelmalek MF, Suzuki A, Cummings OW, Chojkier M, EPE-A Study Group. "No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial." Gastroenterology, vol. 147, no. 2, 2014, pp. 377-84.e1. |
| Cioe PA, Stein MD, Promrat K, Friedmann PD. "A comparison of modified directly observed therapy to standard care for chronic hepatitis C." Journal of Community Health, vol. 38, no. 4, 2013, pp. 679-84. |
| Leggio L, Promrat K, Kenna GA. "A Call to Action: Alcohol Interventions in HIV-Infected Patients." Frontiers in Psychiatry, vol. 3, 2012, pp. 35. |
| Fine S, Hyder S, Promrat K. "Acute upper gastrointestinal bleed in a patient with underlying malignancy." Gastroenterology, vol. 143, no. 4, 2012, pp. 894, 1120-1. |
| Ramsey SE, Engler PA, Stein MD, Brown RA, Cioe P, Kahler CW, Promrat K, Rose J, Anthony J, Solomon DA. "Effect of CBT on Depressive Symptoms in Methadone Maintenance Patients Undergoing Treatment for Hepatitis C." J Addict Res Ther, vol. 2, no. 2, 2011, pp. 2-10. |
| Promrat K, Longato L, Wands JR, de la Monte SM. "Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels." Hepatology research : the official journal of the Japan Society of Hepatology, vol. 41, no. 8, 2011, pp. 754-62. |
| Shieh K, Gilchrist JM, Promrat K. "Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy." Muscle & nerve, vol. 41, no. 2, 2010, pp. 197-201. |
| Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. "Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis." Hepatology, vol. 51, no. 1, 2010, pp. 121-9. |
| Mallette C, Flynn MA, Promrat K. "Outcome of screening for hepatitis C virus infection based on risk factors." American Journal of Gastroenterology, vol. 103, no. 1, 2008, pp. 131-7. |
| Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, Borg B, Loomba R, Liang TJ, Premkumar A, Hoofnagle JH. "The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis." Hepatology, vol. 46, no. 2, 2007, pp. 424-9. |
| Lee P, Promrat K, Mallette C, Flynn M, Beutler E. "A juvenile hemochromatosis patient homozygous for a novel deletion of cDNA nucleotide 81 of hemojuvelin." Acta haematologica, vol. 115, no. 1-2, 2006, pp. 123-7. |
| Uwaifo GI, Tjahjana M, Freedman RJ, Lutchman G, Promrat K. "Acanthosis nigricans in patients with nonalcoholic steatohepatitis: an uncommon finding." Endocrine Practice, vol. 12, no. 4, 2006, pp. 371-9. |
| Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, Hoofnagle JH. "Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement." Clinical Gastroenterology and Hepatology, vol. 4, no. 8, 2006, pp. 1048-52. |
| Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH. "A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis." Hepatology, vol. 39, no. 1, 2004, pp. 188-96. |
| Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ. "Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C." Gastroenterology, vol. 124, no. 2, 2003, pp. 352-60. |
| Promrat K, Liang TJ. "Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?." Hepatology, vol. 38, no. 6, 2003, pp. 1359-62. |
| Wu CH, Ouyang EC, Walton C, Promrat K, Forouhar F, Wu GY. "Hepatitis B virus infection of transplanted human hepatocytes causes a biochemical and histological hepatitis in immunocopetentent rats." World journal of gastroenterology : WJG, vol. 9, no. 5, 2003, pp. 978-83. |
| Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ. "Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin." Hepatology, vol. 38, no. 1, 2003, pp. 66-74. |
| Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, Herion D, Park Y, Liang TJ, Hoofnagle JH. "Progression of fibrosis in chronic hepatitis C." Gastroenterology, vol. 124, no. 1, 2003, pp. 97-104. |
| Soza A, Everhart JE, Ghany MG, Doo E, Heller T, Promrat K, Park Y, Liang TJ, Hoofnagle JH. "Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C." Hepatology, vol. 36, no. 5, 2002, pp. 1273-9. |
| Ouyang EC, Wu CH, Walton C, Promrat K, Wu GY. "Transplantation of human hepatocytes into tolerized genetically immunocompetent rats." World journal of gastroenterology : WJG, vol. 7, no. 3, 2001, pp. 324-30. |
| Promrat K, Wu GY, Wu CH. "Gene therapy for metabolic diseases of the liver." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, vol. 13, no. 3, 2000, pp. 177-88. |
Current Research
1) CSP #577 (Dominitz/Robertson, Co-Chairs) 10/1/2010-9/30/2025
VA Cooperative studies Program
Colonoscopy vs. Fecal Immunochemical Test for Reduction in Mortality from Colorectal Cancer
The major goal of this project is to determine if colonoscopy is superior to FOBT for the prevention of colorectal cancer mortality.
Role: Site principal investigator
2) P20 GM130414-03 (PI: Monti) Subproject ID 8644 (PI: Treloar Padovano) 02/01/2021 – 01/31/2024
Biobehavioral Pathways Underlying Alcohol Use Disorder and Alcohol-associated Liver Disease.
Role: Co-Investigator
Completed Research Funding
1) RO3 DK067263-01A1 Promrat (PI)
NIH/NIDDK Weight management in Nonalcoholic Steatohepatitis (NASH)
Role: Principal Investigator
2) RO1 DA016797 Ramsey (PI)
NIH/NIDA Preventing Depression in MMT Patients on Interferon
Role: Co-Investigator
| Year | Degree | Institution |
|---|---|---|
| 1992 | MD | Chiang Mai University |
| Fellow | NIDDK, National Institutes of Health, Liver Diseases Branch | 2000-2002 | Bethesda, MD, USA |
| Fellow | University of Connecticut, gastroenterology | 1997-2000 | Farmington, CT, USA |
| Professor of Medicine, Clinician Educator track. BROWN UNIVERSITY, 2024- |
| Interim Director, Division of Gastroenterology. Brown University , 2023- |
| Chief, Section of Gastroenterology. VA Providence Health System, 2006- |
UNIVERSITY TEACHING ROLES
BIOL 3670: IMS IV, Integrated Medical Sciences in Gastroenterology (2003-present)
1. Physiology of the liver
2. Bilirubin/Jaundice/Cholestasis
3. Chronic Liver Diseases
4. Pharmacology of the liver I
5. Pharmacology of the liver II
Longitudinal Clinic Preceptor (Hepatology clinic, RIH) (2002-present)
University of Rhode Island (URI) PharmD program: Lecturer, Cirrhosis and its complications (2006-2019)
Academic Scholar Program, Brown Medical School
